甲状腺结节及颈部淋巴结细针穿刺活检技术规范

II参考文献ADDINZOTERO_BIBL{"uncited":[],"omitted":[],"custom":[]}CSL_BIBLIOGRAPHY[1] 中华医学会内分泌分会,中华医学会外科学分会甲状腺及代谢外科学组,中国抗癌协会头颈肿瘤专业委员会,等.甲状腺结节和分化型甲状腺癌诊治指南(第二版)[J].中华内分泌代谢杂志,2023,39(3):181-226.【请重新确认文献参考类型】[2] 田文,孙辉,贺青卿.超声引导下甲状腺结节细针穿刺活检专家共识及操作指南(2018版)[J].中国实用外科杂志,2018,38(03):241-244.[3] 国家癌症中心,国家肿瘤质控中心甲状腺癌质控专家委员会.中国甲状腺癌规范诊疗质量控制指标(2022版)[J].中华肿瘤杂志,2022,44(09):902-907.【请重新确认文献信息准确性，无法检索到该文献】[4] 郭又铭,霍金龙,瞿锐,等.无负压对比负压细针穿刺在甲状腺结节中比较的Meta分析[J].临床耳鼻咽喉头颈外科杂志,2018,32(11):868-872.[5] HsiaoV,MassoudE,JensenC,etal.DiagnosticAccuracyofFine-NeedleBiopsyintheDetectionofThyroidMalignancy[J].JAMASurgery,2022,157(12):1105.【请补全文献名称】[6] 中华人民共和国国家卫生健康委员会医政医管局.甲状腺癌诊疗指南（2022年版）[J].中国实用外科杂志,2022,42(12):1343-1357+1363.[7] HaugenBR,AlexanderEK,BibleKC,etal.2015AmericanThyroidAssociationManagementGuidelinesforAdultPatientswithThyroidNodulesandDifferentiatedThyroidCancer:TheAmericanThyroidAssociationGuidelinesTaskForceonThyroidNodulesandDifferentiatedThyroidCancer[J].Thyroid,2016,26(1):1-133.【请重新确认文献信息准确性，无法检索到该文献】[8] NationalComprehensiveCancerNetwork.ThyroidCarcinoma,Version4.2024,NCCNClinicalPracticeGuidelinesinOncology[EB/OL].(2024)./.【链接请具体至具体网页，而非官网页面的网址】[9] 中华医学会病理学分会细胞病理学组.甲状腺细针穿刺细胞病理学诊断专家共识（2023版）[J].中华病理学杂志,2023,52(5):441-446.【请重新确认文献信息准确性，无法检索到该文献】[10] AliSZ,BalochZW,Cochand-PriolletB,etal.The2023BethesdaSystemforReportingThyroidCytopathology[J].Thyroid,2023,33(9):1039-1044.【请重新确认文献信息准确性，无法检索到该文献】[11] GraniG,SponzielloM,FilettiS,etal.Thyroidnodules:diagnosisandmanagement[J].NatureReviewsEndocrinology,2024.【请重新确认文献信息准确性，无法检索到该文献，并且补全文献卷号、期号、页码范围】[12] PaschkeR,CantaraS,CrescenziA,etal.EuropeanThyroidAssociationGuidelinesregardingThyroidNoduleMolecularFine-NeedleAspirationCytologyDiagnostics[J].EuropeanThyroidJournal,2017,6(3):115-129.[13] FumagalliC,SerioG.Moleculartestinginindeterminatethyroidnodules:anadditionaltoolforclinicaldecision-making[J].Pathologica,2023,115(4):205-216.[14] 罗定远,廖健伟.甲状腺癌基因检测与临床应用广东专家共识(2020版)[J].中华普通外科学文献(电子版),2020,14(3):161-168.【建议修改为电子文献，不用“J”】[15] 张帅,周乐.甲状腺结节性质诊断的细针穿刺洗脱液检查研究进展[J].中国实验诊断学,2024,28(5):594-598.[16] ZhuX,ZhouJ,QianY,etal.Diagnosticvaluesofthyroglobulininlymphnodefine-needleaspirationwashout:asystematicreviewandmeta-analysisdiagnosticvaluesofFNA-Tg[J].EndocrineJournal,2020,67(2):113-123.[17] 徐成,王璐璐,王少华.洗脱液甲状腺球蛋白在甲状腺乳头状癌转移淋巴结中的应用[J].中华普外科手术学杂志（电子版）,2023,17(6):701-704.【建议修改为电子文献，不用“J”】[18] LiuQ,MaoL,ZhangZ,etal.DiagnosticEfficacyofFNA-TginDTCCervicalLNMetastasisanditsImpactFactors:ALargeRetrospectiveStudy[J].TheJournalofClinicalEndocrinology&Metabolism,2023,108(12):3311-3319.[19] 中华医学会超声医学分会浅表器官和血管学组,中国甲状腺与乳腺超声人工智能联盟.2020甲状腺结节超声恶性危险分层中国指南：C-TIRADS[J].中华超声影像学杂志,2021,30(03):185-200.【请重新确认文献信息准确性，无法检索到该文献】[20] 中国医师协会介入医师分会超声介入专业委员会.超声引导下甲状腺结节及颈部淋巴结穿刺专家共识（2023版）[J].中华内科杂志,2024,63(06):550-559.【请重新确认文献信息准确性，无法检索到该文献】[21] 中国超声医学工程学会浅表器官及外周血管专业委员会.甲状腺及相关颈部淋巴结超声若干临床常见问题专家共识(2018版)[J].中国超声医学杂志,2019,35(3):193-204.[22] 中华医学会内分泌学分会,中华医学会围产医学分会.妊娠和产后甲状腺疾病诊治指南(第2版)[J].中华内分泌代谢杂志,2019,35(8):636-665.【建议将年份修改为2020年】[23] 张帅,付庆锋,何润东,等.超声引导下重复细针穿刺活检术对BethesdaⅢ类甲状腺结节临床管理的影响[J].中华内分泌外科杂志,2024,18(4):489-493.【请重新确认文献信息准确性，无法检索到该文献】[24] TrimboliP,D’AurizioF,TozzoliR,et.al.Measurementofthyroglobulin,calcitonin,andPTHinFNAwashoutfluids[J].ClinicalChemistryandLaboratoryMedicine,2017,55(7).【请重新确认文献信息准确性，无法检索到该文献】[25] 林又佳,薛恩生,林礼务,等.超声引导FNAC联合FNA-Tg测定对DTC术前颈部淋巴结转移的诊断价值[J].中国超声医学杂志,2021,37(6):614-617.[26] KahramangilB,KoseE,DonmezM,etal.Thyroglobulinwashoutfromcervicallymphnodefineneedleaspirationbiopsiesinpatientswithdifferentiatedthyroidcancer:ananalysisofdifferentexpressionstouseinpost-totalthyroidectomyfollow-up[J].Surgery,2020,167(1):34-39.[27] LiW,DimD,PaulsonL,etal.Diagnosisofintrathyroidalectopicthymusinthyroidfineneedleaspirationsamples[J].JournalofClinicalPathology,2019,72(2):145-151.[28] CavalloAC,PitoiaF,RobertiJ,etal.OptimizingDiagnosticAccuracyofFineNeedleAspirationBiopsyCalcitoninMeasurementsinDetectingMedullaryThyroidCarcinoma[J].Thyroid,2024,34(2):186-196.【请重新确认文献信息准确性，无法检索到该文献】[29] TrimboliP,GiannelliJ,MarquesB,etal.Head-to-headcomparisonofFNAcytologyvs.calcitoninmeasurementinFNAwashoutfluids(FNA-CT)todiagnosemedullarythyroidcarcinoma.Asystematicreviewandmeta-analysis[J].Endocrine,2022,75(1):33-39.[30] MarquesB,CunhaN,MartinsRG,etal.LymphNodeMetastasesofMedullaryThyroidCancer:RoleofCalcitoninintheWashoutFluidofFine-NeedleAspiration[J].InternationalJournalofEndocrinology,2020,2020:1-6.[31] GÖKÇAYCANPOLATA,ŞAHİNM,CEYHANK,etal.Calcitoninlevelsinwashoutsamplesvs.cytologyinthedetectionofmalignantlymphnodemetastasisinrecurrentmedullarythyroidcancer[J].TURKISHJOURNALOFMEDICALSCIENCES,2021,51(6):3061-3066.【请重新确认文献信息准确性，无法检索到该文献】[32] MikosińskiP,Wołowiec-KoreckaE,PomorskiL,etal.Cut-offValueforThyroglobulinWashoutConcentrationintheDetectionofCervicalLymphNodeMetastasesinPatientsafterThyroidectomyDuetoDifferentiatedThyroidCancer[J].Biomedicines,2023,11(9):2433.【请重新确认文献信息准确性，无法检索到该文献】[33] JeonMJ,KimWG,JangEK,etal.ThyroglobulinLevelinFine-NeedleAspiratesforPreoperativeDiagnosisofCervicalLymphNodeMetastasisinPatientswithPapillaryThyroidCarcinoma:TwoDifferentCutoffValuesAccordingtoSerumThyroglobulinLevel[J].Thyroid,2015,25(4):410-416.[34] MoonJH,KimYI,LimJA,etal.ThyroglobulininWashoutFluidFromLymphNodeFine-needleAspirationBiopsyinPapillaryThyroidCancer:Large-scaleValidationoftheCutoffValuetoDetermineMalignancyandEvaluationofDiscrepantResults[J].JournalofClinicalEndocrinology&Metabolism,2013,98(3):1061-1068.【请重新确认文献信息准确性，无法检索到该文献】[35] 付庆锋,周乐,边学海,等.甲状腺乳头状癌颈部淋巴结转移FNA-Tg诊断标准值的探讨[J].中华内分泌外科杂志,2013,7(2):154-156.【请重新确认文献信息准确性，无法检索到该文献】[36] ZhangX,HowellJM,HuangY.CervicalLymphNodeFine-NeedleAspirationandNeedle-WashThyroglobulinReflexTestforPapillaryThyroidCarcinoma[J].EndocrinePathology,2018,29(4):346-350.[37] HuangY,ChanSJ,WrightJD,etal.DoestheAdoptionofMolecularTestingCauseDecreasedThyroidectomyRatesinaNationalCohort?AQuasiexperimentalStudyofHigh-VersusLow-AdoptionStates[J].Thyroid,2024,34(3):388-398.[38] NgoHTT,NguyenTPX,VuTH,etal.ImpactofMolecularTestingontheManagementofIndeterminateThyroidNodulesAmongWesternandAsianCountries:aSystematicReviewandMeta-analysis[J].EndocrinePathology,2021,32(2):269-279.【请重新确认文献信息准确性，无法检索到该文献】[39] StewardsonP,EszlingerM,WuJ,etal.ProspectiveValidationofThyroSPECMolecularTestingofIndeterminateThyroidNoduleCytologyFollowingDiagnosticPathwayOptimization[J].Thyroid,2023,33(12):1423-1433.【请重新确认文献信息准确性，无法检索到该文献】[40] KimNE,RaghunathanRS,HughesEG,etal.BethesdaIIIandIVThyroidNodulesManagedNonoperativelyAfterMolecularTestingWithAfirmaGSCorThyroseqv3[J].JournalofClinicalEndocrinology&Metabolism,2023,108(9):e698-e703.[41] JiangM,YuY,YangA.ConcernsRegardingThermalAblationforPapillaryThyroidCancer[J].JAMASurgery,2024.【请补全期号、刊号、页码范围】[42] 嵇庆海,程若川,田文.对《甲状腺乳头状癌热消融治疗专家共识（2024版）》部分内容的探讨[J].中华耳鼻咽喉头颈外科杂志,2024,59(10):1088-1093.【请重新确认文献信息准确性，无法检索到该文献】[43] GraniG,SponzielloM,FilettiS,etal.Thyroidnodules:diagnosisandmanagement[J].NatureReviewsEndocrinology,2024.【请补全期号、刊号、页码范围】[44] SchummMA,ShuML,HughesEG,etal.PrognosticValueofPreoperativeMolecularTestingandImplicationsforInitialSurgicalManagementinThyroidNodulesHarboringSuspected(BethesdaV)orKnown(BethesdaVI)PapillaryThyroidCancer[J].JAMAOtolaryngology–Head&NeckSurgery,2023,149(8):735-742.【请重新确认文献信息准确性，无法检索到该文献】[45] LiuJB,BaughKA,RamonellKM,etal.MolecularTestingPredictsIncompleteResponsetoInitialTherapyinDifferentiatedThyroidCarcinomaWithoutLateralNeckorDistantMetastasisatPresentation:RetrospectiveCohortStudy[J].Thyroid,2023,33(6):705-714.[46] KustD,StaničićJ,MatešaN,etal.Bethesdathyroidcategoriesandfamilyhistoryofthyroiddisease[J].ClinicalEndocrinology,2018,88(3):468-472.【请重新确认文献信息准确性，无法检索到该文献】[47] 中国抗癌协会家族遗传性肿瘤专业委员会.中国家族遗传性肿瘤临床诊疗专家共识（2021年版）（5）——家族遗传性甲状腺癌[J].中国肿瘤临床,2022,49(1):6-11.[48] FuG,ChazenRS,MonteiroE,etal.FacilitationofDefinitiveCancerDiagnosisWithQuantitativeMolecularAssaysofBRAFV600EandTERTPromoterVariantsinPatientsWithThyroidNodules[J].JAMANetworkOpen,2023,6(7):e2323500.【请补全文献名称】[49] MoonS,SongYS,KimYA,etal.EffectsofCoexistentBRAFV600EandTERTPromoterMutationsonPoorClinicalOutcomesinPapillaryThyroidCancer:AMeta-Analysis[J].Thyroid,2017,27(5):651-660.【请补全文献名称】[50] GallantJ-N,ChenS-C,OrtegaCA,etal.EvaluationoftheMolecularLandscapeofPediatricThyroidNodulesandUseofaMultigeneGenomicClassifierinChildren[J].JAMAOncology,2022,8(9):1323.【单页文献不建议引用，领域经典和前沿发现除外】[51] StewardDL,CartySE,SippelRS,etal.PerformanceofaMultigeneGenomicClassifierinThyroidNodulesWithIndeterminateCytology[J].JAMAOncology,2019,5(2):204-212.【补全文献名称】[52] 罗定远,廖健伟.甲状腺癌RET基因检测与临床应用专家共识（2021版）[J].中华普通外科学文献(电子版),2022,16(1):1-8.[53] BarlettaJA,NoséV,SadowPM.GenomicsandEpigenomicsofMedullaryThyroidCarcinoma:FromSporadicDiseasetoFamilialManifestations[J].EndocrinePathology,2021,32(1):35-43.【请重新确认文献信息准确性，无法检索到该文献】[54] 殷德涛.实用甲状腺疾病诊疗——甲状腺结节细针穿刺活检术[M].河南:郑州大学出版社,2021.[55] 孙辉,周乐.实用甲状腺结节细针穿刺活检技术[M].吉林:吉林科学技术出版社,2018.【请重新确认文献信息准确性，无法检索到该文献】[56] 周乐,张广,张大奇,等.超声引导下甲状腺结节细针穿刺活检临床应用及质量控制研究[J].中国实用外科杂志,2015,35(6):650-652.[57] 章建全,陈红琼,闫磊,等.对甲状腺结节细针穿刺有关问题的新思考[J].中华医学超声杂志（电子版）,2024,20(10):1007-1011.【请重新确认文献信息准确性，无法检索到该文献】[58] LvT,MaW,TanZ,etal.LevelIIlateralneckdissectionforpapillarythyroidcarcinoma:Aretrospectivecohortstudy[J].Asian